STAMPS: South Carolina Buprenorphine Treatment Initiation, Adherence, and Retention Utilizing Mobile Health Units and Peer Support Specialists
Development, Refinement, and Validation of a Peer Support Specialist Checklist for Individuals With Opioid Use Disorder / STAMPS: South Carolina Buprenorphine Treatment Initiation, Adherence, and Retention Utilizing Mobile Health Units and Peer Support Specialists
2 other identifiers
interventional
90
1 country
2
Brief Summary
The study is a 1-arm prospective interventional cohort quasi-experimental with retrospective control group. Enrolled participants will be compared to previously established mobile health patients, who did not work with a peer recovery coach, for buprenorphine treatment and adherence outcomes. 90 patients will be recruited from the mobile health units in rural counties in Upstate South Carolina. Visits consist of a baseline and 3 month follow up. The study will focus to develop, deliver, and evaluate an innovative 1) Peer Support Specialist (PSS) intervention to increase Medications for Opioid Use Disorder (MOUD) initiation and retention rates in rural populations and underserved communities, and 2) dynamic modeling framework to prioritize at-risk communities for delivery of Mobile Health Clinics. the interventions will be developed in the R61 phase and implemented in a pilot study to determine the effectiveness on initiation and retention. With opioid overdose deaths continuing to rise in South Carolina (SC) and nationally, our sustainable framework has potential to prevent hundreds to thousands of opioid overdoses in SC and can be scaled up in other regions to save many more lives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 25, 2024
CompletedStudy Start
First participant enrolled
May 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedOctober 23, 2025
October 1, 2025
1.2 years
April 22, 2024
October 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Medication for Opioid Use Disorder (MOUD) Initiation
MOUD initiation is defined as receipt of first MOUD prescription within the 3-month study period
3 months
MOUD Retention
MOUD retention is defined as receipt of 75% of weekly MOUD prescriptions in first 3 months since MOUD initiation
3 months
Study Arms (1)
Peer Support Specialist Intervention
EXPERIMENTALEligible participants will be linked to a peer support specialist. Peer support specialists are Certified Peer Support Specialists (CPSS) who have lived experience with opioid use disorder (OUD) and OUD recovery. Peer support specialists offer consistent personalized recovery support and generalized social support. Peer support specialists will maintain contact and provide support for the participant for 3 months post-baseline utilizing the newly validated checklist.
Interventions
Peer support specialists are Certified Peer Support Specialists (CPSS) who have lived experience with Opioid Use Disorder (OUD) and OUD recovery. Peer support specialists offer consistent personalized recovery support and generalized social support. Peer support specialists will maintain contact and provide support for the participant for six-months post-baseline. CPSS will utilize the newly developed checklist from earlier phases of the project to provide patient support.
Eligibility Criteria
You may qualify if:
- Age 18+
- Have diagnosis of OUD
- New patient of the mobile clinic
You may not qualify if:
- Currently prescribed MOUD
- Currently working with a PSS
- Current suicidal ideation, as verified through the Patient Health Questionnaire-9 (PHQ-9)
- Having a severe medical or psychiatric disability that would hinder participation in the study, as determined by nurse practitioner
- Unable to read/speak English
- Unable to read and comprehend the consent materials and other study materials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prisma Health-Upstatelead
- Clemson Universitycollaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (2)
Prisma Addiction Medicine Center - Mobile Health Clinic
Clinton, South Carolina, 29325, United States
Prisma - Addiction Medicine Center Mobile Health Clinic
Seneca, South Carolina, 29672, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2024
First Posted
April 25, 2024
Study Start
May 2, 2024
Primary Completion
July 31, 2025
Study Completion
July 31, 2025
Last Updated
October 23, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share